France Lifts Clinical Hold From AB Science’s Masitinib

After two years on clinical hold, the French biotech has resolved quality and pharmacovigilance problems that forced it to suspend studies of masitinib, moving it a step closer to restarting trials in its home country.

Birdcage
AB Free To Start trials in France after clinical hold • Source: Shutterstock

France’s drug regulatory agency has lifted a clinical hold from AB Science two years after it suspended development of masitinib in the country.

More from Clinical Trials

More from R&D